期刊文献+
共找到49篇文章
< 1 2 3 >
每页显示 20 50 100
Association between 5-HTR1A gene C-1019G polymorphism and antidepressant response in patients with major depressive disorder:A meta-analysis
1
作者 Huai-Neng Wu Shuang-Yue Zhu +2 位作者 Li-Na Zhang Bian-Hong Shen Lian-Lian Xu 《World Journal of Psychiatry》 SCIE 2024年第10期1573-1582,共10页
BACKGROUND Major depressive disorder(MDD)is a substantial global health concern,and its treatment is complicated by the variability in individual response to antide-pressants.AIM To consolidate research and clarify th... BACKGROUND Major depressive disorder(MDD)is a substantial global health concern,and its treatment is complicated by the variability in individual response to antide-pressants.AIM To consolidate research and clarify the impact of genetic variation on MDD treatment outcomes.METHODS Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines,a systematic search across PubMed,EMBASE,Web of Science,and the Cochrane Library was conducted without date restrictions,utilizing key terms related to MDD,serotonin 1A receptor polymorphism(5-HTR1A),C-1019G polymorphism,and antidepressant response.Studies meeting inclusion criteria were thoroughly screened,and quality assessed using the Newcastle-Ottawa Scale.Statistical analyses,includingχ2 and I²values,were used to evaluate heterogeneity and fixed-effect or random-effect models were applied accordingly.RESULTS The initial search yielded 1216 articles,with 11 studies meeting criteria for inclusion.Analysis of various genetic models showed no significant association between the 5-HTR1A C-1019G polymorphism and antidepressant efficacy.The heterogeneity was low to moderate,and no publication bias was detected through funnel plot symmetry and Egger's and Begg's tests.CONCLUSION This meta-analysis does not support a significant association between the 5-HTR1A C-1019G polymorphism and the efficacy of antidepressant treatment in MDD.The findings call for further research with larger cohorts to substantiate these results and enhance the understanding of antidepressant pharmacogenetics. 展开更多
关键词 Major depressive disorder Antidepressant efficacy 5-HTR1A gene C-1019g polymorphism META-ANALYSIS
下载PDF
PAI-1启动子区4G/5G基因多态性与脑血管病相关性研究 被引量:1
2
作者 张晨 李江 罗兵 《中国免疫学杂志》 CAS CSCD 北大核心 2001年第7期363-366,共4页
目的 :初步探讨人类纤溶酶原激活物抑制物 1(plasminogenactivatorinhibitor,PAI 1)启动子区基因多态性与脑血管病的关系及其在脑血管病发病过程中的作用。方法 :通过多聚酶链反应 (polymerasechainreaction ,PCR)技术和发色底物法(ELI... 目的 :初步探讨人类纤溶酶原激活物抑制物 1(plasminogenactivatorinhibitor,PAI 1)启动子区基因多态性与脑血管病的关系及其在脑血管病发病过程中的作用。方法 :通过多聚酶链反应 (polymerasechainreaction ,PCR)技术和发色底物法(ELISA) ,测定 96例脑血管病病人 ,其中脑梗死 (cerebralinfarction ,CI)组 6 5例 ,脑出血 (cerebralhemorrhage ,CH)组 31例和 6 0例对照组的白细胞PAI 1启动子区 4G/ 5G多态性位点的基因型及血浆PAI 1活性。结果 :CI组血浆PAI 1活性明显高于其它二组 ,各组中均以纯合子 4G/ 4G基因型患者的PAI 1血浆活性水平为最高 ,5G/ 5G基因型最低 ,杂合子 4G/ 5G基因型居中 ;4G纯合子基因型与其它二型之间比较差异均有显著意义 ,4G/ 5G与 5G/ 5G基因型之间比较差异无显著意义。CI组 4G/ 4G纯合子型基因型与对照组 (Controls)比较有显著性差异 (P <0 0 5 ) ,CI组基因型与CH组及CH组与对照组基因型比较均无统计学意义 (P >0 0 5 )。女性CI 4G纯合子基因型患者血浆PAI 1活性与同型男性患者比较有显著性差异。结论 :纯合子 4G/ 4G基因型可能是CI发病的危险因素之一 ,4G纯合子个体可能具有较高的CI发病倾向 。 展开更多
关键词 脑血管病 纤溶酶原激活物换制物 基因多态性 pai-1 启动子 4g/5g
下载PDF
PAI-1 4G/5G基因多态性与脑梗死的关系
3
作者 张爱娟 宋保华 +1 位作者 王敬先 逄迎春 《山东医药》 CAS 北大核心 2003年第31期42-43,共2页
为研究纤溶酶原激活剂抑制物-1(PAI-1)基因长臂启动子区插入/缺失(4G/5G)多态性与脑梗死的相关性,2001年1月至2002年8月,我院对113例脑梗死患者进行了PAI-14G/5G基因检测.现报告如下.
关键词 pai-1 4g/5g 基因多态性 脑梗死 纤溶酶原激活剂抑制物-1
下载PDF
2型糖尿病合并冠心病患者PAI-1基因4G/5G多态性研究
4
作者 商淑华 汪纯 +3 位作者 于永春 顾耀 吴国亭 吴增常 《同济大学学报(医学版)》 CAS 2001年第4期16-19,共4页
目的 探讨 2型糖尿病患者血浆纤溶酶原激活物抑制因子 - 1(PAI - 1)基因启动区 4G/5G多态性及与并发冠心病的关系。方法  118名 2型糖尿病患者 ,按有无冠心病分为两组。未合并冠心病组 80例 ,合并冠心病组38例。应用PCR扩增PAI 1基因... 目的 探讨 2型糖尿病患者血浆纤溶酶原激活物抑制因子 - 1(PAI - 1)基因启动区 4G/5G多态性及与并发冠心病的关系。方法  118名 2型糖尿病患者 ,按有无冠心病分为两组。未合并冠心病组 80例 ,合并冠心病组38例。应用PCR扩增PAI 1基因启动区片段 ,γ32P末端标记 2个序列特异性寡核苷酸 (ASO)进行点杂交 ,比较基因型在两组糖尿病人群中的分布及与血浆PAI 1活性的关系。结果  (1)合并冠心病的 2型糖尿病患者较未合并冠心病组 4G基因型的频率升高 ,但未达统计学意义 (P >0 .0 5 ) ;(2 )两组的血浆PAI 1活性差异明显 (10 .32± 2 .6 5vs8.87± 3 .2 4)kU/L ,P <0 .0 5 ;(3)两组的血TG水平差异明显 (1.99± 1.0 4vs 1.5 6± 0 .72 )mmol/L ,P <0 .0 5 ;(4)两组的空腹胰岛素水平差异明显 (14.6± 5 .8vs 11.2± 4.3)kU/L ,P <0 .0 5 ;(5 )在 4G/4G基因型患者中血浆PAI 1活性与TG明显相关 (r=0 .5 7,P <0 .0 5 )。结论 PAI 1活性升高及PAI 1基因启动区 展开更多
关键词 血浆纤溶酶原激活剂抑制物-1 基因多态性 Ⅱ型糖尿病 4g/5g pai-1冠心病
下载PDF
−675 4G/5G and −844 G/A of Plasminogne Activator Inhibitor-1 (Pai-1) Gene Polymorphisms and Type 2 DiabetesMellitus in Tunisia: Case-Control Study
5
作者 Mohamed Moustapha Molka Chadhli-Chaieb +1 位作者 Touhami Mahjoub Larbi Chaieb 《Open Journal of Endocrine and Metabolic Diseases》 2019年第7期75-83,共9页
Background: The plasminogen activator inhibitor-1 (PAI-1) is a puissant antifibrinolytic factor;plasma PAI-1 level is high in type 2 diabetes. 4G/5G polymorphism of PAI-1 gene is a major genetic determinant of plasma ... Background: The plasminogen activator inhibitor-1 (PAI-1) is a puissant antifibrinolytic factor;plasma PAI-1 level is high in type 2 diabetes. 4G/5G polymorphism of PAI-1 gene is a major genetic determinant of plasma PAI-1 levels, with 4G carriers having high PAI-1 level than 5G, theses pose the question about relation T2 patients and those polymorphisms. The aim of this study was to determine the relationship between the polymorphisms &minus;675 4G/5G and &minus;844 G/A of PAI-1 gene and type 2 diabetes mellitus. Methods: A case control study of 491 diabetic and 400 healthy controls. Genotyping of the polymorphism &minus;675 4G/5G was done by PCR-ASA (polymerase chain reaction, allele specific amplification), and the polymorphism &minus;844 G/A was done with PCR-RFLP (restriction fragment length polymorphism), the allelic frequency is calculated with hardy-Weinberg law, the statistic analysis was done by SPSS version 10. Results: Higher frequencies of The genotypes 4G/4G (p = 0.01) and 4G/5G of polymorphism &minus;675 4G/5G were seen in diabetic (p = 0.05) and higher frequencies of 5G/5G was seen in controls (p &minus;844 G/A was seen in diabetics and G/G was seen in controls (p = 0.01). Conclusion: Our study found association between 4G allele of &minus;675 4G/5G and A allele of &minus;844 G/A of PAI-1 gene and having type 2 diabetes mellitus in Tunisian population. 展开更多
关键词 Plasminogéne Activator Inhbitor-1 (pai-1) ?675 4g/5g Polymorphism ?844 g/A Polymorphism Type 2 Diabetes Mellitus
下载PDF
高血压病患者甘油三酯与PAI-1及其基因4G/5G多态性的关系 被引量:1
6
作者 车琳 陈义汉 +1 位作者 宋艳丽 徐文渊 《兰州医学院学报》 2000年第3期21-23,共3页
目的 探讨在高血压病患者中甘油三酯与纤溶酶原激活物抑制剂 1(PAI 1)及其基因多态性的关系。方法 随机收集上海地区汉族人种原发性高血压病例 2 4 0例 (男 12 0例、女 12 0例 ,年龄范围 33~ 89岁 ,平均 65岁 ) ,血浆PAI 1由ELISA... 目的 探讨在高血压病患者中甘油三酯与纤溶酶原激活物抑制剂 1(PAI 1)及其基因多态性的关系。方法 随机收集上海地区汉族人种原发性高血压病例 2 4 0例 (男 12 0例、女 12 0例 ,年龄范围 33~ 89岁 ,平均 65岁 ) ,血浆PAI 1由ELISA法测得 ,PAI 14G/ 5G基因型分析采用等位基因特异性寡核苷酸探针斑点杂交方法。结果 ①甘油三酯与血浆PAI 1水平呈显著正相关 (P <0 0 1) ,甘油三酯是血浆PAI 1水平的独立影响因素 (P =0 0 0 1,血酯在PAI 1基因 4G/ 5G多态性的分布无统计学意义 (P >0 0 5)。②血浆PAI 1水平与PAI 1基因 4G/ 5G多态性相关 ( (P =0 0 0 1) ,PAI 1基因型为血浆PAI 1水平的独立影响因素。结论 在高血压病患者中 ,甘油三酯与PAI 1呈显著正相关 ,并且甘油三酯是血浆PAI 1水平的独立影响因素。 展开更多
关键词 pai-1 4g/5g多态性 甘油三酯 原发性高血压
下载PDF
自身免疫性疾病患者检测PAI-1(4G/5G),ABCB1(3435T>C)在预防甲强龙治疗发生股骨头坏死风险的应用 被引量:6
7
作者 张莹 程晓东 +3 位作者 胡玉皎 王昊 周铁成 郝晓柯 《现代检验医学杂志》 CAS 2019年第2期14-16,19,共4页
目的检测化学药物甲强龙的耐药位点PAI-1(4G/5G)和ABCB1(3435T>C),为使用甲强龙治疗的患者提供精准的用药指导,避免股骨头坏死风险的发生。方法收集94例血液样本,使用荧光探针原位杂交技术对甲强龙耐药位点PAI-1(4G/5G)和ABCB1(3435T... 目的检测化学药物甲强龙的耐药位点PAI-1(4G/5G)和ABCB1(3435T>C),为使用甲强龙治疗的患者提供精准的用药指导,避免股骨头坏死风险的发生。方法收集94例血液样本,使用荧光探针原位杂交技术对甲强龙耐药位点PAI-1(4G/5G)和ABCB1(3435T>C)进行检测和分析,评估不同患者甲强龙药物使用的可行性。结果 94例患者中,PAI-1(4G/5G)位点检测结果5G5G(野生型)的患者20例(21.28%),检测结果4G5G(杂合突变型)的患者43例(45.74%),检测结果4G4G(纯合突变型)的患者31例(32.98%);ABCB1(3435T>C)位点检测结果TT(野生型)的患者17例(18.09%),检测结果TC(杂合突变型)的患者44例(46.81%),检测结果CC(纯合突变型)的患者33例(35.10%)。12.77%的患者进行激素甲强龙冲击治疗时引起股骨头坏死的风险为低风险,60.63%的患者进行激素甲强龙冲击治疗时引起股骨头坏死的风险为中等风险,26.60%的患者进行激素甲强龙冲击治疗时引起股骨头坏死的风险是高风险。使用卡方检验,激素甲强龙化学药物两个耐药位点间检测结果对于评估股骨头坏死的风险度没有差异。结论在进行糖皮质激素甲强龙冲击治疗前给患者作甲强龙化学药物耐药基因检测,根据检测结果精准用药,可以使26.59%的患者避免股骨头坏死风险的出现,为患者提供安全的用药指导。 展开更多
关键词 pai-1(4g/5g) ABCB1(3435T>C) 甲强龙 激素性股骨头坏死
下载PDF
PAI-1(4G/5G)和ABCB1 C3435T基因与狼疮继发股骨头坏死的相关性 被引量:2
8
作者 李思佳 张葵 +4 位作者 郑艳 刘薇 冯媛 李英 吴振彪 《山西医科大学学报》 CAS 2018年第11期1359-1362,共4页
目的分析PAI-1(4G/5G)和ABCB1 C3435T基因多态性与狼疮继发股骨头坏死(SLE-ONFH)的相关性。方法纳入我院2016-06~2017-06符合入组标准的40例SLE患者的临床资料,其中SLE-ONFH组19例,无股骨头坏死(ONFH)的SLE患者21例为对照组。对受试者... 目的分析PAI-1(4G/5G)和ABCB1 C3435T基因多态性与狼疮继发股骨头坏死(SLE-ONFH)的相关性。方法纳入我院2016-06~2017-06符合入组标准的40例SLE患者的临床资料,其中SLE-ONFH组19例,无股骨头坏死(ONFH)的SLE患者21例为对照组。对受试者抽取空腹肘静脉血,用数字荧光分子杂交技术(DFMH)测定各组PAI-1(4G/5G)和ABCB1 C3435T基因多态性,其中PAI-1(4G/5G)基因4G4G型、ABCB1 C3435T基因CC型为高危型。结果 SLE-ONFH组和对照组PAI-1(4G/5G)基因4G4G型的频率分别为31. 6%,14. 3%,差异无统计学意义(χ~2=1. 71,P> 0. 05); SLE-ONFH组和对照组ABCB1 C3435T基因CC型的频率分别为52. 6%,19%,差异有统计学意义(χ~2=4. 94,P <0. 05)。结论 ABCB1C3435T基因与SLE-ONFH存在相关性,可能成为筛查SLE-ONFH高危人群的指标之一。 展开更多
关键词 系统性红斑狼疮 股骨头坏死 pai-1(4g/5g)基因 ABCB1 C3435T基因
下载PDF
甘蔗渣淀粉功能降解菌筛选及s2g5-1和s3g4-8的鉴定 被引量:4
9
作者 贺军军 罗萍 +3 位作者 李勤奋 易润华 陈永辉 戴小红 《安徽农业科学》 CAS 北大核心 2011年第13期7711-7714,共4页
[目的]筛选甘蔗淀粉功能降解菌,并对菌株s2g5-1和s3g4-8进行鉴定。[方法]利用多种选择性培养基,从自然发酵不同阶段的甘蔗渣中分离到多种淀粉分解菌,并对其进行初筛和复筛。[结果]获得了淀粉降解功能菌株s2g5-1和s3g4-8。通过形态、生... [目的]筛选甘蔗淀粉功能降解菌,并对菌株s2g5-1和s3g4-8进行鉴定。[方法]利用多种选择性培养基,从自然发酵不同阶段的甘蔗渣中分离到多种淀粉分解菌,并对其进行初筛和复筛。[结果]获得了淀粉降解功能菌株s2g5-1和s3g4-8。通过形态、生理生化和分子综合鉴定得出s2g5-1和s3g4-8菌株均为解淀粉芽孢杆菌。[结论]该研究结果为甘蔗渣工厂化应用提供了理论依据。 展开更多
关键词 甘蔗渣 淀粉降解菌 s2g5-1 s3g4-8
下载PDF
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与IgA肾病肾小球硬化的相关性研究 被引量:3
10
作者 何立群 肖黎 +1 位作者 郑平东 章晓鹰 《上海医学》 CAS CSCD 北大核心 2003年第11期815-817,共3页
目的 探讨原发性肾小球疾病患者中纤溶酶原激活物抑制物 1(PAI 1)基因多态性及其产物与IgA肾病肾小球硬化的关系。 方法 随机收集上海地区汉族人种IgA肾病患者 98例 ,其中伴肾小球硬化者 (G组 ) 5 3例 (5 4 % ) ,无肾小球硬化者 (no... 目的 探讨原发性肾小球疾病患者中纤溶酶原激活物抑制物 1(PAI 1)基因多态性及其产物与IgA肾病肾小球硬化的关系。 方法 随机收集上海地区汉族人种IgA肾病患者 98例 ,其中伴肾小球硬化者 (G组 ) 5 3例 (5 4 % ) ,无肾小球硬化者 (non G组 ) 4 5例 (46 % ) ,另设 95名健康体检者为对照组。采用发色底物法测定血浆PAI 1,采用等位基因特异多聚酶链反应 (ASPCR)法进行PAI 14G/ 5G基因型分析。结果 G组的 4G/4G基因型发生频率 (45 .3% )、4G等位基因频率 (0 .6 7% )显著高于non G组 (13.3%、0 .4 1% ,P值均 <0 .0 5 )。而G组 5G/ 5G基因型的发生频率 (11.3% )则显著低于non G组 (31.1% ,P <0 .0 5 ) ;IgA肾病患者和对照组中携带 4G/ 4G基因的患者血浆PAI 1水平显著高于其他基因型 (P值分别 <0 .0 5和 <0 .0 1)。结论 PAI 14G/4G基因型和 4G等位基因与肾小球硬化显著相关 ,PAI 14G/ 4G基因型携带者血浆PAI 展开更多
关键词 纤溶酶原激活物抑制剂-1 基因启动子区 4g/5g 基因多态性 IgA肾病 肾小球硬化
下载PDF
Screening of Starch-degrading Strains in Bagasse and Identification of Strains s2g5-1 and s3g4-8 被引量:2
11
作者 贺军军 罗萍 +3 位作者 李勤奋 易润华 陈永辉 戴小红 《Agricultural Science & Technology》 CAS 2011年第1期45-49,共5页
[Objective]The study aimed to screen the starch-degrading bacterium in bagasse and carry on the identification of strains s2g5-1 and s3g4-8.[Method]By using a variety of selective media,varieties of starch degrading b... [Objective]The study aimed to screen the starch-degrading bacterium in bagasse and carry on the identification of strains s2g5-1 and s3g4-8.[Method]By using a variety of selective media,varieties of starch degrading bacterium were isolated from the sugar cane bagasse form different stages of natural fermentation,then,primary screening and secondary screening were performed.[Result] Starch-degrading strains s2g5-1 and s3g4-8 were screened,and they were identified as Bacillus amyloliquefaciens according to their morphological,physiological,biochemical and molecular characteristics.[Conclusion]The research provided theoretical basis for factory application of bagasse. 展开更多
关键词 BAgASSE Starch-degrading bacteria s2g5-1 s3g4-8
下载PDF
冠心病合并阻塞性睡眠呼吸暂停低通气综合征患者纤溶酶原激活物抑制物-1启动子区4G/5G基因多态性分析 被引量:2
12
作者 王言森 王少媛 +2 位作者 张敏 白春学 李善群 《新医学》 北大核心 2003年第11期674-676,共3页
目的:研究冠状动脉粥样硬化性心脏病(冠心病)合并阻塞性睡眠呼吸暂停低通气综合征(obstructivesleepapnea-hypopneasyndrome,OSAHS)患者纤溶酶原激活物抑制物-1(plasminogenactivatorinhibitor-1,PAI-1)含量(PAI-1∶Ag)和活性(PAI-1∶A)... 目的:研究冠状动脉粥样硬化性心脏病(冠心病)合并阻塞性睡眠呼吸暂停低通气综合征(obstructivesleepapnea-hypopneasyndrome,OSAHS)患者纤溶酶原激活物抑制物-1(plasminogenactivatorinhibitor-1,PAI-1)含量(PAI-1∶Ag)和活性(PAI-1∶A)与PAI-1启动子区4G/5G等位基因多态性及表达的关系。方法:确诊为冠心病的患者67例,依据睡眠呼吸监测的结果分为合并OSAHS组与不合并OSAHS组。另从同期体格检查的健康人群中选出60名,年龄与上述两组匹配,依据睡眠呼吸监测的结果分为正常对照组与OSAHS组。分别测定4组的血浆PAI-1∶A、PAI-1∶Ag与PAI-1启动子区4G/5G位点基因多态性及信使核糖核酸(messengerribonucleicacid,mRNA)表达。结果:冠心病合并OSAHS组5G/5G基因型出现频率显著低于对照组(38%比70%),4G/5G、4G/4G并4G/5G基因型出现频率显著高于对照组(53%比23%,63%比30%)。不同基因型对mRNA表达有不同的影响,其中4G/4G基因型mRNA表达最高(3.6±0.5),其次为4G/5G基因型(3.1±0.4),5G/5G基因型mRNA表达最低(1.2±0.8)。不同基因型mRNA的表达量与血浆PAI-1∶A和PAI-1∶Ag水平呈显著正相关。结论:冠心病合并OSAHS患者具有较高的4G/4G、4G/5G基因频率,具有较高的mRNA表达水平,PAI-1∶A、PAI-1∶Ag含量较高。 展开更多
关键词 冠心病 合并症 阻塞性睡眠呼吸暂停低通气综合征 纤溶酶原激活物抑制物-1 启动子区 4g/5g基因 基因多态性 冠状动脉粥样硬化性心脏病
下载PDF
(Z)-7-苯亚甲基-5H-二苯并[b,g][1,4]氧氮杂环辛-6(7H)-酮的合成
13
作者 唐建生 莫敏 郑敏 《化学世界》 CAS CSCD 北大核心 2013年第11期679-681,688,704,共5页
以2-碘苯酚和2-氟硝基苯为原料,经Ullmann缩合、还原、Sonogashira偶联、羰基环化反应首次合成了(Z)-7-苯亚甲基-5 H-二苯并[b,g][1,4]氧氮杂环辛-6(7 H)-酮,总收率34.9%。产物结构经1 H NMR、13C NMR和MS表征。
关键词 (Z)-7-苯亚甲基-5 H-二苯并[b g][1 4]氧氮杂环辛-6(7 H)-酮 分子内羰基化 合成
下载PDF
纤溶酶原激活物抑制剂-1(4G/5G)基因多态性与深静脉血栓事件的风险概率 被引量:11
14
作者 张莹 程晓东 +4 位作者 胡玉皎 王昊 周铁成 郝晓柯 刘家云 《临床检验杂志》 CAS 2020年第7期513-515,共3页
目的分析我国西北地区纤溶酶原激活物抑制剂-1(PAI-1)(4G/5G)基因在不同人群中的分布情况,以及不同基因型患者血栓事件的发生率,为携带PAI-1(4G/5G)基因4G型的手术患者提供数据支持和用药指导。方法收集1494例行基因位点检测人群血液样... 目的分析我国西北地区纤溶酶原激活物抑制剂-1(PAI-1)(4G/5G)基因在不同人群中的分布情况,以及不同基因型患者血栓事件的发生率,为携带PAI-1(4G/5G)基因4G型的手术患者提供数据支持和用药指导。方法收集1494例行基因位点检测人群血液样本,使用荧光探针原位杂交技术检测PAI-1(4G/5G)基因位点,分析我国西北地区PAI-1(4G/5G)基因在体检健康者、剖腹产患者、烧伤患者、心脑血管疾病患者之间4G基因型的差异性。结果336例体检健康者中5G5G(野生型)78例(23.21%),4G5G(杂合突变型)152例(45.24%),4G4G(纯合突变型)106例(31.55%)。401例剖腹产患者中5G5G(野生型)60例(14.96%),4G5G(杂合突变型)195例(48.63%),4G4G(纯合突变型)146例(36.41%)。603例烧伤患者中5G5G(野生型)100例(16.58%),4G5G(杂合突变型)295例(48.93%),4G4G(纯合突变型)208例(34.49%)。154例心脑血管疾病患者中5G5G(野生型)21例(13.64%),4G5G(杂合突变型)81例(52.59%),4G4G(纯合突变型)52例(33.77%)。剖腹产患者、烧伤患者、心脑血管疾病患者PAI-1(4G/5G)基因4G型携带率与体检健康人群间的差异均有统计学意义(P<0.05)。追踪观察200例烧伤手术患者,患病后2个月内有139例(69.5%)发生深静脉血栓事件,4G4G基因型血栓事件为86.49%(64/74),4G5G基因型血栓事件为65.00%(52/82),5G5G基因型血栓事件为50.00%(23/46),不同基因型深静脉血栓事件发生率的差异有统计学意义(P<0.01)。结论通过分析PAI-1(4G/5G)基因在不同人群中的分布以及发生血栓事件的发生率,可预防或降低手术患者发生静脉血栓、脑卒中等的风险。 展开更多
关键词 纤溶酶原激活物抑制剂-1(4g/5g) 脑卒中 易栓症
下载PDF
Synthesis, Structural Characterization and DFT Studies of Silver(I) Complex Salt of Bis(4,5-dihydro-1<i>H</i>-benzo[g]indazole) 被引量:1
15
作者 Tanyi Rogers Fomuta Golngar Djimassingar +3 位作者 Jean Ngoune Nana Odette Ngnabeuye Jean Jacques Anguile Justin Nenwa 《Crystal Structure Theory and Applications》 2017年第2期11-24,共14页
A new silver complex salt [Ag(N2C11H10)2]NO3 (where N2C11H10 = 4,5-dihydro-1H-benzo[g]indazole), has been synthesized and characterized by elemental and thermal analyses, IR and 1HNMR spectroscopies, single crystal X-... A new silver complex salt [Ag(N2C11H10)2]NO3 (where N2C11H10 = 4,5-dihydro-1H-benzo[g]indazole), has been synthesized and characterized by elemental and thermal analyses, IR and 1HNMR spectroscopies, single crystal X-ray structure determination and DFT studies. Its molecular structure comprises of a silver center coordinated to two nitrogen atoms from two 4,5-dihydro-1H-benzo[g]indazole molecule giving rise to a cationic complex entity, [Ag(N2C11H10)2]+ with as counter ion. The bulk structure is consolidated by N–H…O, C–H…π, Ag…π and Ag…O intermolecular interactions, thus generating a pseudo-helical network. The optimized structure, frontier molecular orbitals (HOMO and LUMO) and global reactivity descriptors were investigated by performing DFT calculations. 展开更多
关键词 SILVER Complex Salt 4 5-dihydro-1H-benzo[g]indazole Hydrogen Bonds THERMOgRAVIMETRIC Analysis 1HNMR X-Ray DFT Studies
下载PDF
Sequence analysis of VP4 genes of wild type and culture adapted human rotavirus G1P[8]strains
16
作者 Ritu Arora Ganesh S Dhale +1 位作者 Pooja R Patil Shobha D Chitambar 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2011年第7期541-546,共6页
Objective:To conduct a comparative analysis of the VP4 gene sequences of Indian wild type (06361,0613158,061060 and 0715880) and cell culture adapted(06361-CA,0613158-CA.061060- CA and 0715880-CA) G1P[8]rotavirus stra... Objective:To conduct a comparative analysis of the VP4 gene sequences of Indian wild type (06361,0613158,061060 and 0715880) and cell culture adapted(06361-CA,0613158-CA.061060- CA and 0715880-CA) G1P[8]rotavirus strains.Methods:Full-length VP4 genes of each of the four wild type G1P[8]rotavirus strains and their cell culture adapted counterparts displaying consistent cytopathic effect were subjected to RT-PCR amplification and nucleotide sequencing. Results:All four cell culture adapted G1P[8]rotavirus strains showed nucleotide and amino acid substitutions in the VP4 gene as compared to their wild type strains.The number of substitutions however,varied from 1-64 and 1-13 respectively.The substitutions were distributed in both VP5* and VP8* subunits of VP4 gene respectively of permeabilizalion and hemagglutinaling activity. The presence of unique amino acid substitutions was identified in two of the four wild type(V377G. S387N in 061060 and 1644L in 0715880) and all four cell culture adapted(A46V in 0613158-CA. T60R in 06361-CA,L237V.G389V and Q480H in 061060-CA and S615G and T625P in 0715880-CA) strains for the first time in the VP4 gene of P[8]specificity.Amino acid substitutions generated increase in the hydrophilicity in the cell culture adapted rotavirus strains as compared to their corresponding wild type strains.Conclusions:Amino acid substitutions detected in the VP4 genes of G1P[8]rotavirus strains from this study together with those from other studies highlight occurrence of only strain and/or host specific substitutions during cell culture adaptation. Further evaluation of such substitutions for their role in attenuation,immunogenicity and conformation is needed for the development of newer rolavirus vaccines. 展开更多
关键词 ROTAVIRUS Cell CULTURE g1P[8] VP4 gene
下载PDF
PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis
17
作者 Linda Pasta Francesca Pasta 《World Journal of Hepatology》 CAS 2015年第29期2920-2926,共7页
AIM To evaluate the different roles of thrombophiliain patients with and without viral etiology. The thrombophilicgenetic factors (THRGFs), PAI-1 4G-4G, MTHFR677TT, V Leiden 506Q and prothrombin 20210A,were studied ... AIM To evaluate the different roles of thrombophiliain patients with and without viral etiology. The thrombophilicgenetic factors (THRGFs), PAI-1 4G-4G, MTHFR677TT, V Leiden 506Q and prothrombin 20210A,were studied as risk factors in 1079 patients with livercirrhosis (LC), enrolled from January 2000 to January2014.METHODS: All Caucasian LC patients consecutivelyobserved in a seven year period were included; thepresence of portal vein thrombosis (PVT) and BuddChiari syndrome (BCS) was registered. The differencesbetween the proportions of each THRGF with regardto the presence or absence of viral etiology and thefrequencies of the THRGF genotypes with those predictedin a population by the Hardy-Weinberg equilibriumwere registered.RESULTS: Four hundred and seventeen/one thousandand seventy-six patients (38.6%) showed thrombophilia:217 PAI-1 4G-4G, 176 MTHFR C677TT, 71 V Leidenfactor and 41 prothrombin G20210 A, 84 with morethan 1 THRGF; 350 presented with no viral liver cirrhosis(NVLC) and 729 with, called viral liver cirrhosis (VLC),of whom 56 patients were hepatitis C virus + hepatitisB virus. PAI-1 4G-4G, MTHFR C677TT, the presence ofat least one TRHGF and the presence of 〉 1 THRGF,were statistically more frequent in patients with NVLC vspatients with VLC: All χ 2 〉 3.85 and P 〈 0.05. Patientswith PVT and/or BCS with at least one TRHGF were189/352 (53.7%). The Hardy-Weinberg of PAI-1 andMTHFR 677 genotypes deviated from that expectedfrom a population in equilibrium in patients with NVLC(respectively χ 2 = 39.3; P 〈 0.000 and χ 2 = 27.94; P 〈0.05), whereas the equilibrium was respected in VLC.CONCLUSION: MTHFR 677TT was nearly twofold andPAI-1 4G-4G more than threefold more frequently foundin NVLC vs patients with VLC; the Hardy-Weinbergequilibrium of these two polymorphisms confirms thisdata in NVLC. We suggest that PAI-1 4G-4G and MTHFR677TT could be considered as factors of fibrosis andthrombosis mechanisms, increasing the inflammationresponse, and causing the hepatic fibrosis and augmentedintrahepatic vascular resistance typical of LC. PAI-14G-4G and MTHFR 677TT screening of LC patientscould be useful, mainly in those with NVLC, to identifypatients in which new drug therapies based on theattenuation of the hepatic stellate cells activation orother mechanisms could be more easily evaluated. 展开更多
关键词 pai-1 4g-4g MTHFR 677TT V Leiden506Q PROTHROMBIN 20210A Liver cirrhosis Portal veinthrombosis BUDD CHIARI syndrome FIBROgeneSIS
下载PDF
Synthesis, Rietveld Refinement and DFT Studies of Bis(4,5-dihydro-1<i>H</i>-benzo[g]indazole)silver(I) Hexafluorophosphate Complex Salt
18
作者 Tanyi Rogers Fomuta Jean Ngoune +4 位作者 Golngar Djimassingar Tayo Alain Djampouo Junior Ma Ntep Tobie Matemb Jean Jacques Anguile Justin Nenwa 《Open Journal of Inorganic Chemistry》 2017年第4期102-115,共14页
The new salt bis(4,5-dihydro-1H-benzo[g]indazole)silver(I) hexafluorophosphate, [Ag(N2H10C11)2]PF6, has been synthesized in methanol at ambient temperature and characterized by elemental and thermal analyses, FTIR and... The new salt bis(4,5-dihydro-1H-benzo[g]indazole)silver(I) hexafluorophosphate, [Ag(N2H10C11)2]PF6, has been synthesized in methanol at ambient temperature and characterized by elemental and thermal analyses, FTIR and 1HNMR spectroscopies, Rietveld refinement from powder diffraction data and DFT studies. The salt crystallizes in the triclinic space group P-1 with the parameters: a = 7.776 ?, b = 8.676 ?, c = 9.226 ?, α = 69.27° β = 89.86°, γ = 74.50°, V = 558.02 ?3, Z = 1. In the structure, the silver center is coordinated to two nitrogen atoms from two 4,5-dihydro-1H-benzo[g]indazole ligands, forming a centrosymmetric complex cation, [Ag(N2H10C11)2]+, with a linear coordination geometry around the silver center. The hexafluorophosphate ion, , acts as counter anion. The crystal packing is governed by N-H···F and C-H···F hydrogen bonds that interconnect the ionic constituents and Ag···F and Ag···π interactions help for the stabilization of the packing. The optimized structure was obtained at B3LYP/LanL2DZ level in the gas phase. The stability and reactivity of the structure were studied using respectively HOMO-LUMO gap and electronic global quantities (ionization potential (I) and electron affinity (A)) as descriptors. 展开更多
关键词 SILVER Complex Salt 4 5-dihydro-1H-benzo[g]indazole 1HNMR Powder Diffraction Rietveld Refinement DFT
下载PDF
RGS4过表达对甲基苯丙胺依赖大鼠纹状体mGluR5信号传导通路相关蛋白表达的影响 被引量:2
19
作者 赵林波 隋念含 +4 位作者 蒙国懿 洪仕君 李利华 邢豫明 赵永娜 《中国药理学通报》 CAS CSCD 北大核心 2019年第8期1115-1120,共6页
目的 通过建立大鼠甲基苯丙胺(METH)依赖条件位置偏爱模型(CPP),研究脑纹状体内G蛋白信号调节因子4(RGS4)过表达引起的代谢型谷氨酸受体5(mGluR5)信号传导通路相关蛋白表达变化,以及对大鼠CPP行为的影响。方法将大鼠随机分为正常组、生... 目的 通过建立大鼠甲基苯丙胺(METH)依赖条件位置偏爱模型(CPP),研究脑纹状体内G蛋白信号调节因子4(RGS4)过表达引起的代谢型谷氨酸受体5(mGluR5)信号传导通路相关蛋白表达变化,以及对大鼠CPP行为的影响。方法将大鼠随机分为正常组、生理盐水(NS)组、METH组、Ad5-RGS4-EGFP组、Ad5-EGFP组。正常组不做处理,其余各组脑纹状体分别立体定位注射磷酸盐缓冲液(PBS)、PBS、过表达腺病毒载体Ad5-RGS4-EGFP和阴性对照腺病毒载体Ad5-EGFP,分析各组大鼠CPP行为,Western blot检测脑纹状体内RGS4、mGluR5、Gαq、PLCβ1等蛋白的表达。结果 Ad5-RGS4-EGFP组CPP差值低于METH组和Ad5-EGFP组(P<0.05),高于NS组(P<0.05)。Ad5-RGS4-EGFP组RGS4蛋白表达均不同程度高于其余4组(P<0.05,P <0.01),mGluR5、Gαq表达低于METH组和Ad5-EGFP组(P<0.05),略高于正常组和NS组( P >0.05),PLCβ1表达略有变化,但差异无显著性。结论纹状体内RGS4过表达可明显缓解METH成瘾性大鼠CPP行为,机制可能与RGS4过表达后,负性调控mGluR5介导的Gαq及PLCβ1信号传导通路相关。 展开更多
关键词 甲基苯丙胺 纹状体 条件位置偏爱 g蛋白信号调节因子4 代谢型谷氨酸受体5 g蛋白α亚单位蛋白q 磷脂酶C-β1
下载PDF
甲基苯丙胺依赖对大鼠纹状体RGS4和mGluR5受体信号传导的影响 被引量:1
20
作者 赵林波 隋念含 +3 位作者 李利华 洪仕君 邢豫明 赵永娜 《中国临床药理学与治疗学》 CAS CSCD 2018年第5期536-540,共5页
目的:研究甲基苯丙胺依赖不同时间对大鼠脑纹状体内G蛋白信号调节因子4(regulator of G-protein signaling 4,RGS4)和代谢型谷氨酸受体5(metabotropic receptor 5,m GluR5)信号传导的影响。方法:建立大鼠甲基苯丙胺(methamphetamine,ME... 目的:研究甲基苯丙胺依赖不同时间对大鼠脑纹状体内G蛋白信号调节因子4(regulator of G-protein signaling 4,RGS4)和代谢型谷氨酸受体5(metabotropic receptor 5,m GluR5)信号传导的影响。方法:建立大鼠甲基苯丙胺(methamphetamine,METH)依赖一周组(1W)、两周组(2W)模型,Western blot技术检测大鼠纹状体内RGS4、m GluR5、G蛋白α亚单位蛋白Q(Gαq)、磷脂酶C-β1(phospholipase C-β,PLCβ1)表达水平。结果:METH依赖1W、2W组伴药箱停留时间比生理盐水对照组增加,提示METH依赖模型建成。模型组大鼠纹状体内RGS4蛋白表达水平较生理盐水对照组相比明显下调,而模型组m GluR5蛋白和Gαq蛋白、PLCβ1蛋白表达与生理盐水对照组比较均有不同程度上调,且2W组较1W组改变更明显。结论:METH给药可能导致大鼠脑纹状体内RGS4表达下调,m GluR5表达上调,还可使与m GluR5偶联的Gαq、PLCβ1表达均出现不同程度上调。且METH依赖时间越长,RGS4、m GluR5、Gαq、PLCβ1的表达水平变化越显著。 展开更多
关键词 甲基苯丙胺 纹状体 条件位置偏爱 g蛋白信号调节因子4 代谢型谷氨酸受体5 g蛋白α亚单位蛋白Q 磷脂酶C-β1
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部